WA
IDXX icon

WealthTrust Axiom’s Idexx Laboratories IDXX Stock Holding History

WealthTrust Axiom’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Sell
408
-1
-0.2% -$561 0.05% 272
2026
Q1 		$230K Hold
409
– – 0.06% 247
2025
Q4 		$277K Hold
409
– – 0.07% 208
2025
Q3 		$261K Hold
409
– – 0.07% 211
2025
Q2 		$219K Buy
+409
New +$196K 0.06% 228
2024
Q4 		– Sell
-416
Closed -$210K – 264
2024
Q3 		$210K Hold
416
– – 0.06% 233
2024
Q2 		$203K Hold
416
– – 0.07% 223
2024
Q1 		$225K Hold
416
– – 0.07% 216
2023
Q4 		$231K Buy
+416
New +$195K 0.08% 203
2023
Q3 		– Sell
-476
Closed -$239K – 248
2023
Q2 		$239K Buy
+476
New +$228K 0.08% 201
2022
Q2 		– Sell
-382
Closed -$208K – 264
2022
Q1 		$208K Hold
382
– – 0.07% 221
2021
Q4 		$251K Sell
382
-16
-4% -$10K 0.08% 200
2021
Q3 		$247K Sell
398
-42
-10% -$28.2K 0.08% 194
2021
Q2 		$277K Buy
+440
New +$243K 0.09% 189

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

WealthTrust Axiom's IDXX Position: Q2 2026 in Review

WealthTrust Axiom reduced its Idexx Laboratories (IDXX) stake by 0.24% in Q2 2026, selling an estimated $561 and leaving 408 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #272.

WealthTrust Axiom first reported a position in IDXX in Q2 2021 and has held it in 14 quarters since. The position peaked at $277K in Q2 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • WealthTrust Axiom held 408 shares of Idexx Laboratories worth $215K as of Q2 2026.
  • WealthTrust Axiom sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up 0.05% of WealthTrust Axiom's portfolio in Q2 2026, its #272 holding.
  • WealthTrust Axiom first reported a position in Idexx Laboratories in Q2 2021 and has held it in 14 quarters since.
  • WealthTrust Axiom's Idexx Laboratories position peaked at $277K in Q2 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on WealthTrust Axiom's 13F filing for Q2 2026, filed 11 Aug 2026.